Cargando…
Potential of mesenchymal stem cells as topical immunomodulatory cell therapies for ocular surface inflammatory disorders
Ocular surface inflammatory disorders (OSIDs) are a group of highly prevalent, heterogeneous diseases that display a variety of aetiologies and symptoms and are risk factors for serious complications, including ocular and cornea impairment. Corneal inflammation is a common factor of all OSIDs, regar...
Autores principales: | Beeken, Lydia J., Ting, Darren S.J., Sidney, Laura E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780815/ https://www.ncbi.nlm.nih.gov/pubmed/32896982 http://dx.doi.org/10.1002/sctm.20-0118 |
Ejemplares similares
-
Ocular Surface Regeneration by Limbal Stem Cells Therapies: State of the Art, Challenges, and Perspectives
por: Bonnet, Clémence, et al.
Publicado: (2023) -
Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells
por: Wang, Li‐Tzu, et al.
Publicado: (2021) -
Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID‐19
por: Yen, B. Linju, et al.
Publicado: (2020) -
Accidental Ocular Injury by Topical Dermatological Agent: Potassium Permanganate (KMnO4)
por: Kandpal, Renu, et al.
Publicado: (2021) -
The emerging antioxidant paradigm of mesenchymal stem cell therapy
por: Stavely, Rhian, et al.
Publicado: (2020)